These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 9489835

  • 21. Markers of inflammation and atherosclerosis in Egyptian patients with systemic lupus erythematosus.
    Sabry AA, Elbasyouni SR, Kalil AM, Abdel-Rahim M, Mohsen T, Sleem A.
    Nephrology (Carlton); 2006 Aug; 11(4):329-35. PubMed ID: 16889573
    [Abstract] [Full Text] [Related]

  • 22. [Clinical value of soluble tumor necrosis factor-alpha receptors in patients with systemic lupus erythematosus].
    Krichevskaia OA, Kliukvina NG, Aleksandrova EN, Samsonov MIu, Nasonov EL.
    Klin Med (Mosk); 2004 Aug; 82(10):51-5. PubMed ID: 15584602
    [Abstract] [Full Text] [Related]

  • 23. [Roles of serum and urinary interleukins 13Ralpha2 and other cytokines in pediatric Henoch-Schonlein purpura].
    Yu YH, Pan KL, Li Q, Zhang BJ, Huang Y, Zhang JJ, DU L.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):37-40. PubMed ID: 19149920
    [Abstract] [Full Text] [Related]

  • 24. [Serum levels of tumor necrosis factor alpha and soluble tumor necrosis factor-receptor I in asthmatic patients and patients with chronic respiratory tract infection].
    Sumitomo M, Suda S, Shindo K, Fukumura M, Fukushima J, Okuda K, Ito A.
    Arerugi; 1997 Nov; 46(11):1136-47. PubMed ID: 9436331
    [Abstract] [Full Text] [Related]

  • 25. Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy?
    Rostoker G, Rymer JC, Bagnard G, Petit-Phar M, Griuncelli M, Pilatte Y.
    Clin Exp Immunol; 1998 Dec; 114(3):468-76. PubMed ID: 9844059
    [Abstract] [Full Text] [Related]

  • 26. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
    Muzaffer MA, Dayer JM, Feldman BM, Pruzanski W, Roux-Lombard P, Schneider R, Laxer RM, Silverman ED.
    J Rheumatol; 2002 May; 29(5):1071-8. PubMed ID: 12022325
    [Abstract] [Full Text] [Related]

  • 27. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
    Maury CP, Liljeström M, Laiho K, Tiitinen S, Kaarela K, Hurme M.
    Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
    [Abstract] [Full Text] [Related]

  • 28. Effects of an intravenous catheter on the local production of cytokines and soluble cytokine receptors in healthy men.
    Haack M, Reichenberg A, Kraus T, Schuld A, Yirmiya R, Pollmächer T.
    Cytokine; 2000 Jun; 12(6):694-8. PubMed ID: 10843747
    [Abstract] [Full Text] [Related]

  • 29. Hemoglobin levels correlate with serum soluble CD23 and TNF-Rs concentrations in patients with rheumatoid arthritis.
    Vaiopoulos G, Boki K, Kapsimali V, Coulocheri S, Papadaki HA, Eliopoulos GD.
    Haematologia (Budap); 1998 Jun; 29(2):89-99. PubMed ID: 9728801
    [Abstract] [Full Text] [Related]

  • 30. Three measures of tumor necrosis factor alpha activity and insulin resistance in nonobese Japanese type 2 diabetic patients.
    Ohya M, Taniguchi A, Fukushima M, Nakai Y, Kawasaki Y, Nagasaka S, Kuroe A, Taki Y, Yoshii S, Hosokawa M, Inagaki N, Seino Y.
    Metabolism; 2005 Oct; 54(10):1297-301. PubMed ID: 16154427
    [Abstract] [Full Text] [Related]

  • 31. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus.
    Lub-de Hooge MN, de Vries EG, de Jong S, Bijl M.
    Ann Rheum Dis; 2005 Jun; 64(6):854-8. PubMed ID: 15564310
    [Abstract] [Full Text] [Related]

  • 32. Pregnancy, cytokines, and disease activity in systemic lupus erythematosus.
    Doria A, Ghirardello A, Iaccarino L, Zampieri S, Punzi L, Tarricone E, Ruffatti A, Sulli A, Sarzi-Puttini PC, Gambari PF, Cutolo M.
    Arthritis Rheum; 2004 Dec 15; 51(6):989-95. PubMed ID: 15593367
    [Abstract] [Full Text] [Related]

  • 33. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Liu ZC, Zhou QL, Li XZ, Yang JH, Ao X, Veeraragoo P, Zuo XX.
    Cytokine; 2011 Mar 15; 53(3):295-300. PubMed ID: 21163672
    [Abstract] [Full Text] [Related]

  • 34. Serum levels and in situ expression of TNF-alpha and TNF-alpha binding proteins in inflammatory liver diseases.
    Spengler U, Zachoval R, Gallati H, Jung MC, Hoffmann R, Riethmüller G, Pape G.
    Cytokine; 1996 Nov 15; 8(11):864-72. PubMed ID: 9047083
    [Abstract] [Full Text] [Related]

  • 35. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
    Perini P, Tiberio M, Sivieri S, Facchinetti A, Biasi G, Gallo P.
    Eur Cytokine Netw; 2000 Mar 15; 11(1):81-6. PubMed ID: 10705303
    [Abstract] [Full Text] [Related]

  • 36. Antinucleosome antibodies correlate with the disease severity in children with systemic lupus erythematosus.
    Wu JF, Yang YH, Wang LC, Lee JH, Shen EY, Chiang BL.
    J Autoimmun; 2006 Sep 15; 27(2):119-24. PubMed ID: 16919912
    [Abstract] [Full Text] [Related]

  • 37. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P, Kvasnicka J, Umlaufová A, Homolková H, Jirsa M, Tesar V.
    Med Sci Monit; 2000 Sep 15; 6(4):661-7. PubMed ID: 11208388
    [Abstract] [Full Text] [Related]

  • 38. Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock.
    Iglesias J, Marik PE, Levine JS, Norasept II Study Investigators.
    Am J Kidney Dis; 2003 Jan 15; 41(1):62-75. PubMed ID: 12500222
    [Abstract] [Full Text] [Related]

  • 39. Tumor necrosis factor-alpha is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population.
    Jiménez-Morales S, Velázquez-Cruz R, Ramírez-Bello J, Bonilla-González E, Romero-Hidalgo S, Escamilla-Guerrero G, Cuevas F, Espinosa-Rosales F, Martínez-Aguilar NE, Gómez-Vera J, Baca V, Orozco L.
    Hum Immunol; 2009 Apr 15; 70(4):251-6. PubMed ID: 19480843
    [Abstract] [Full Text] [Related]

  • 40. [Soluble TNF p55 and p75 receptors in the development of sepsis syndrome].
    Modzelewski B.
    Pol Merkur Lekarski; 2003 Jan 15; 14(79):69-72. PubMed ID: 12712835
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.